Improved Post-Transplant Survival in the United States for Patients with Cholangiocarcinoma After 2000
- Reena J. SalgiaAffiliated withDepartment of Internal Medicine, Taubman Medical Center, University of Michigan Email author
- , Amit G. SingalAffiliated withDepartment of Internal Medicine, University of Texas Southwestern
- , Sherry FuAffiliated withDepartment of Internal Medicine, Taubman Medical Center, University of MichiganSimpson Memorial Institute
- , Shawn PelletierAffiliated withDepartment of General Surgery, University of Virginia
- , Jorge A. MarreroAffiliated withDepartment of Internal Medicine, University of Texas SouthwesternUniversity of Texas Southwestern Medical Center
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The incidence of cholangiocarcinoma (CCA) continues to rise. Orthotopic liver transplantation (OLT) can be used for selected patients with localized but unresectable hilar CCA. Although initial post-OLT survival rates were poor, outcomes after introduction of the Mayo Clinic protocol have been more promising and there has been increased interest in OLT for CCA nationally.
The aim of this study is to determine post-transplant survival and prognostic factors for patients undergoing OLT for CCA.
A retrospective analysis of all patients with CCA listed nationwide for OLT between October 1987 and May 2008 was performed using the Scientific Registry of Transplant Recipients database. Survival curves were generated using the Kaplan–Meier method and compared using log-rank test.
Of 595 patients with CCA listed for OLT, 359 (60.3 %) underwent OLT. Median age at OLT was 49 years, 66 % were male and 91 % were Caucasian. The median follow-up time was 2 years. There has been an increasing number of liver transplants performed for CCA since 2000. The 1- and 5-year probability of survival was 85.8 and 51.4 %, respectively. On multivariate analysis, significant prognostic factors for decreased post-OLT survival included transplant before 2000 (HR 11.25, 95 % CI 1.28–98.7) and acute cellular rejection (HR 5.64, 95 % CI 1.14–27.8).
Survival after transplant for CCA has improved over time, and OLT is being used more frequently in the treatment of CCA. Significant predictors of post-OLT survival include a history of acute rejection and date of transplant in relation to the publication of Mayo protocol results.
KeywordsCholangiocarcinoma Liver transplant Outcomes Survival
- Improved Post-Transplant Survival in the United States for Patients with Cholangiocarcinoma After 2000
Digestive Diseases and Sciences
Volume 59, Issue 5 , pp 1048-1054
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Liver transplant
- Industry Sectors
- Author Affiliations
- 1. Department of Internal Medicine, Taubman Medical Center, University of Michigan, 1500 E. Medical Center Drive, Room 3912, SPC 5362, Ann Arbor, MI, 48109, USA
- 2. Department of Internal Medicine, University of Texas Southwestern, 5959 Harry Hines Blvd POB I Suite 420B, Dallas, TX, 75201, USA
- 4. Simpson Memorial Institute, 102 Observatory St., GI-Room 200, SPC5724, Ann Arbor, MI, 48109-5724, USA
- 3. Department of General Surgery, University of Virginia, PO Box 800709, Charlottesville, VA, 22908-0709, USA
- 5. University of Texas Southwestern Medical Center, Professional Office Building 1, Suite 520L, 5959 Harry Hines Blvd., Dallas, TX, USA